Grigorios Siokas Purchases 90,325 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 90,325 shares of the business’s stock in a transaction on Friday, January 23rd. The shares were purchased at an average price of $0.50 per share, with a total value of $45,162.50. Following the transaction, the chief executive officer owned 8,182,120 shares in the company, valued at $4,091,060. The trade was a 1.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Tuesday, January 20th, Grigorios Siokas purchased 353,321 shares of Cosmos Health stock. The shares were purchased at an average price of $0.50 per share, for a total transaction of $176,660.50.
• On Wednesday, January 14th, Grigorios Siokas purchased 493,495 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.45 per share, with a total value of $222,072.75.
• On Monday, January 12th, Grigorios Siokas acquired 113,185 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.50 per share, for a total transaction of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The shares were acquired at an average price of $0.52 per share, for a total transaction of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The stock was acquired at an average price of $0.54 per share, for a total transaction of $72,334.62.
• On Friday, December 19th, Grigorios Siokas bought 88,314 shares of Cosmos Health stock. The shares were bought at an average price of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The stock was bought at an average price of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were bought at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was bought at an average cost of $0.63 per share, with a total value of $35,111.16.

Cosmos Health Price Performance

COSM stock opened at $0.51 on Wednesday. The company has a market cap of $18.92 million, a price-to-earnings ratio of -0.67 and a beta of 5.37. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The firm has a 50 day moving average of $0.52 and a 200-day moving average of $0.74. Cosmos Health Inc. has a 12-month low of $0.28 and a 12-month high of $1.32.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The firm had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. As a group, equities analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC lifted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the quarter. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.